DarioHealth (NASDAQ:DRIO – Get Free Report) posted its quarterly earnings results on Tuesday. The company’s stock had a trading volume of 37,661 shares, compared to its average volume of 15,221. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of DarioHealth in a research report on Friday, July 10th. XTX Topco Ltd now owns 62,511 shares of the company’s stock worth $42,000 after purchasing an additional 43,513 shares in the last quarter. DarioHealth Company Profile(Get Free Report)DarioHealth (NASDAQ:DRIO) is a digital health company specializing in chronic disease management through a smartphone-based care platform.